How many drugs treat severe asthma?

Drug Landscape tracks 4 marketed treatments for severe asthma (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/severe-asthma.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

severe asthma — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

severe asthma (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating severe asthma, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Exdensur	DEPEMOKIMAB	Glaxosmithkline Llc		Histamine	2025-01-01
Tezspire	AMG 157	AstraZeneca	Thymic Stromal Lymphopoietin Blocker [EPC]	Thymic stromal lymphopoietin	2021-01-01
TEZSPIRE	TEZEPELUMAB-EKKO	ASTRAZENECA AB	Thymic Stromal Lymphopoietin Blocker [EPC]	Thymic stromal lymphopoietin
Tezspire	Tezspire	Qilu Pharmaceutical Co., Ltd.		Thymic stromal lymphopoietin

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

ASTRAZENECA AB · 1 drug in severe asthma
AstraZeneca · 1 drug in severe asthma
Glaxosmithkline Llc · 1 drug in severe asthma
Qilu Pharmaceutical Co., Ltd. · 1 drug in severe asthma

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in severe asthma:

Cite this brief

Drug Landscape (2026). severe asthma — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/severe-asthma. Accessed 2026-06-10.

severe asthma full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing